People · Operator
Named in public records as an officer, director or promoter · active 2018–2021 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Elevian, Inc. | — | Other | Series B | $38.0M | $287.0M | 2020 |
| Ossium Health, Inc. | — | Biotechnology | Series A | $10.4M | $376.2M | 2018 |
Sebastian Giwa at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sebastian Giwa on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Allen | 1 | 9 |
| Brandon Simmons | 1 | 5 |
| J. Casey McGlynn | 1 | 5 |
| Suzanne Fletcher | 1 | 3 |
| Casey J. McGlynn | 1 | 2 |
| William Trenchard | 1 | 2 |
| Kevin Caldwell | 1 | 2 |
| Daniel Marshak | 1 | 1 |
| Caleb Bell | 1 | 1 |
| Luis Alvarez | 1 | 1 |
| Erik Woods | 1 | 1 |
| Thomas Cycyota | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.